software version 18.0.1 (SPSS Inc)
90
Structured Review
SPSS Inc
software version 18.0.1
Software Version 18.0.1, supplied by SPSS Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+version+18%2E0%2E1/software+version+18+1/pmc05812105-44-9-11
Average 90 stars, based on 1 article reviews
Software Version 18.0.1, supplied by SPSS Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+version+18%2E0%2E1/software+version+18+1/pmc05812105-44-9-11
Average 90 stars, based on 1 article reviews
software version 18.0.1 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessment. Article Snippet: The prognosis for children with high-risk relapsed acute lymphoblastic leukemia (ALL) is poor.. Here, we assessed the prognostic importance of response during induction and consolidation treatment prior to hematopoietic stem cell transplantation (HSCT) aiming to evaluate the best time to assess minimal residual disease (MRD) for intervention strategies and in future trials in high-risk ALL relapse patients.. Included patients (n= 125) were treated uniformly according to the ALL-REZ BFM (Berlin-Frankfurt-Münster) 2002 relapse trial (median follow-up time = 4.8 years). |